KIAA1383 Activators
KIAA1383 activators represent a chemical class of compounds designed to interact with and modulate the activity of the KIAA1383 protein. KIAA1383, also known as FAM55A (Family with sequence similarity 55 member A), is a protein that is still relatively understudied, and its precise functions and biological roles are currently being elucidated. However, early research indicates its potential involvement in cellular processes related to gene expression regulation, protein-protein interactions, and intracellular signaling cascades. KIAA1383 contains a domain with sequence similarity to the Saccharomyces cerevisiae protein Sad1 and the mammalian protein UNC-84 (SUN domain), suggesting potential roles in nuclear envelope organization, nuclear-cytoskeletal interactions, or other nuclear processes. The designation activators implies that compounds within this class interact with KIAA1383 to influence its activity, potentially leading to downstream effects on cellular physiology and molecular pathways.
Research into KIAA1383 activators involves unraveling the molecular mechanisms underlying their interaction with the KIAA1383 protein and how this interaction affects cellular processes. Understanding the pharmacological properties of these compounds is crucial for deciphering how they impact KIAA1383 activity and potentially influence gene expression, protein interactions, or other cellular functions. By elucidating the biological functions and regulatory mechanisms of KIAA1383, researchers aim to deepen our understanding of cellular biology and may uncover novel insights into the molecular pathways underlying cellular homeostasis. Continued exploration of KIAA1383 activators holds promise for advancing our knowledge of cellular physiology and may provide insights into new strategies for manipulating cellular function in experimental contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules by binding to β-tubulin, potentially increasing the stability of microtubule structures and influencing MAP10 activity as MAP10 is associated with microtubule stabilization and assembly. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule polymerization. In response to microtubule depolymerization, cellular mechanisms may upregulate MAPs, including MAP10, to restore stability. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, which increases cAMP levels and may modulate microtubule dynamics by influencing MAP10 activity via cAMP-dependent protein kinase (PKA) signaling pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium affects glycogen synthase kinase-3 (GSK-3) activity, which is involved in microtubule dynamics. Inhibition of GSK-3 could upregulate MAPs, including MAP10, and enhance microtubule stability. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been found to influence numerous cellular pathways. It may indirectly affect MAP10 activity through modulation of cell signaling pathways that govern cytoskeletal dynamics. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin, inhibiting microtubule polymerization. In response, cells might increase expression of MAPs like MAP10 to counteract the destabilizing effects. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine binds to tubulin and prevents microtubule assembly. Cells may react by upregulating microtubule-associated proteins such as MAP10 to attempt to preserve microtubule integrity. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, as a precursor of NAD+, could influence cellular metabolism and indirectly affect MAP10 activity by altering the cellular energy state and affecting microtubule dynamics. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol impacts multiple signaling pathways and may affect MAP10 indirectly by altering the cellular environment and microtubule-associated processes. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate impacts cellular folate metabolism and could influence the expression of various proteins, including potentially MAP10, by altering the availability of methyl groups necessary for gene expression regulation. | ||||||